Zenotech Laboratories Limited

BSE:532039 Stock Report

Market Cap: ₹4.3b

Zenotech Laboratories Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Sachin Gavandare

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure8.8yrs
Board average tenure9.1yrs

Recent management updates

Recent updates

CEO

Sachin Gavandare

less than a year

Tenure

Dr. Sachin Laxmanappa Gavandare is Chief Executive Officer of Zenotech Laboratories Limited from October 23, 2024. He has years of rich experience in the pharma industry. He was earlier associated with Cur...

Leadership Team

NamePositionTenureCompensationOwnership
Sachin Gavandare
Chief Executive Officerless than a yearno datano data
Kachappilly Poly
Chief Financial Officer9.6yrs₹993.00kno data
K. Reddy
Head of HR & Adminno datano datano data
Abdul Mohammad
Company Secretary & Compliance Officer8.8yrs₹67.98kno data
Ramesh Kumar
Head of Engineeringno datano datano data
Sanjay Agarwal
Head of Productionno datano datano data
Chandrasekhar Dasu
Head of Qualityno datano datano data

8.8yrs

Average Tenure

Experienced Management: 532039's management team is seasoned and experienced (8.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kavita Shah
Independent Non-Executive Director9.7yrs₹75.00kno data
Jignesh Goradia
Non Independent Non-Executive Director9.4yrs₹75.00kno data
Azadar Hussain Asghar Khan
Non-Independent Non-Executive Chairman9.3yrsno datano data
Chintan Shah
Independent Non-Executive Director8.9yrs₹75.00kno data
Jagruti Sheth
Independent Non-Executive Director4.8yrs₹75.00kno data
Rakeshchandra Sinha
Non-Independent Non Executive Director4.8yrsno datano data

9.1yrs

Average Tenure

57yo

Average Age

Experienced Board: 532039's board of directors are considered experienced (9.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:01
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zenotech Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution